Fig. 4From: A high-throughput screening system for SARS-CoV-2 entry inhibition, syncytia formation and cell toxicityValidation of SiHa ACE2 Cerulean H2B mCherry cells using known cytotoxic compound Arsenic trioxide (As2O3—µM) anti-spike human monoclonal antibody Casirivimab (mAb—nM). Control—VSV-eGFP-SARS-CoV-2 infection without drug. The nuclear condensation is visible in Arsenic treatmentBack to article page